Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]
- 31 August 2004
- journal article
- correction
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 23 (1), 93
- https://doi.org/10.1016/j.jaut.2004.04.001